Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Hosun Biological Technology is a biotechnology company headquartered in Qingdao, China, dedicated to the advancement of cell-based therapies and regenerative medicine. The company specializes in the extraction, expansion, and storage of mesenchymal stem cells (MSCs) and immune cells, operating a large-scale biological sample bank. Hosun Bio's research focuses on clinical applications for chronic diseases, oncology, and anti-aging treatments. They maintain GMP-standard laboratories to ensure the quality and safety of their cell products for clinical research and personalized health services. The company integrates R&D, cell storage, and health management to provide comprehensive biological solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Hosun Biological Technology.